Journal
ACCOUNTS OF CHEMICAL RESEARCH
Volume 39, Issue 9, Pages 635-645Publisher
AMER CHEMICAL SOC
DOI: 10.1021/ar050063s
Keywords
-
Categories
Funding
- NIA NIH HHS [AG027818, AG18921, AG023661] Funding Source: Medline
- NINDS NIH HHS [NS38328, NS44147] Funding Source: Medline
Ask authors/readers for more resources
Oligomeric, neurotoxic amyloid protein assemblies are thought to be causative agents in Alzheimer's and other neurodegenerative diseases. Development of oligomer-specific therapeutic agents requires a mechanistic understanding of the oligomerization process. This is a daunting task because amyloidogenic protein oligomers often are metastable and comprise structurally heterogeneous populations in equilibrium with monomers and fibrils. A single methodological approach cannot elucidate the entire protein assembly process. An integrated multidisciplinary program is required. We discuss here the synergistic application of in hydro, in vacuo, and in silico methods to the study of the amyloid beta-protein, the key pathogenetic agent in Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available